STEM CELLS & REGENERATIVE MEDICINE

In Your Child’s Lifetime, Stem Cells Could:

regenerative medicine reverses tissue damage

Reverse Tissue Damage

regenerative medicine_replace_organs

Repair & Replace Organs

regenerative medicine cures disease

Treat & Cure Disease

Stem cells are the building blocks of all the different types of cells that make up the body’s blood, tissues, and organs. They have the remarkable ability to transform into other types of cells and replenish themselves as needed. Due to their transformative potential, some stem cells can be used to replace other cells in the body that are abnormal or have been destroyed by disease. Banking stem cells may play a role in a long and healthy future for your family.

Your child will grow up in a different world filled with new opportunities.

One of the most exciting areas of medical advancement is regenerative medicine, a revolutionary new pillar in health care. Regenerative medicine involves repairing damaged tissue, repairing organs, and curing life-threatening diseases. Stem cell banking with Lifebank ensures that your child and your family are in the best position to use advancements in this groundbreaking field.

Only Lifebank Lets You Bank More Stem Cells & More Life-Saving Opportunities

Why Bank Cord Blood?

Banking stem cells from the umbilical cord has been the foundation for stem cell banking, with a long and proven history of life-saving treatments, but only Lifebank offers advanced methodology and a personalized approach.

Why Bank Placental Tissue?

Lifebank preserves your baby’s placental tissue using the same steps taken to process stem cells for FDA-approved clinical trials. These stem cells have been used in hundreds of patients with serious conditions. Placental tissue banking is an important consideration for you and your family. It gives you the ability to take advantage of, and benefit from, future medical advancements as they happen.

Why Bank Placental Stem Cells?

Using more stem cells in a transplant has been shown to lead to higher transplant success and survival.12,13,14 Did you know that you can be better prepared to take advantage of current therapies by banking your baby’s unique stem cells that come from placental blood as well as cord blood? Stem cells found in placental blood are also part of a growing area of stem cell research that promises to lead to groundbreaking new therapies in the future.

stem-cells-and-regenerative-medicine-figure-anatomy

Banking the Best for the Future

Stem cells found in placental blood, placental tissue, and cord blood are the cornerstone of the exciting science of regenerative medicine. In your child’s lifetime, these stem cells may provide treatments for a number of life-threatening diseases.

Stem Cells and Regenerative Medicine

Being researched today as investigational treatment for:

  • Spinal cord injury12
  • Diabetes Mellitus 20
  • Autism 21
  • Parkinson’s disease13
  • Cerebral palsy14
  • Muscular dystrophy15
  • Stroke16
  • Autoimmune diseases2

Prepare your family for the future of medicine

REFERENCES & NOTES

  1. Data on file, LifebankUSA; 2016.
  2. Silini AR, Cargnoni A, Magatti A, Pianta S, Parolini O. The long path of human placenta, and its derivatives, in regenerative medicine. Front Bioeng Biotechnol. 2015; 3:162.
  3. New York Medical College. Human Placental-Derived Stem Cell Transplantation (HPDSC). Available at: https://clinicaltrials.gov/ct2/show/NCT01586455. Updated October 4, 2016. Accessed January 11, 2017.
  4. The Prince Charles Hospital. A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis (MSC in IPF). Available at: https://clinicaltrials.gov/ct2/show/NCT01385644. Updated November 24, 2015. Accessed January 11, 2017.
  5. New York Medical College. Autologous Cord Blood and Human Placental Derived Stem Cells in Neonates With Severe Hypoxic-Ischemic Encephalopathy (HPDSC+HIE). Available at: https://clinicaltrials.gov/ct2/show/NCT02434965. Updated October 4, 2016. Accessed January 11, 2017.
  6. Yen BL, Huang H-I, Chien C-C, Jui H-Y, Ko B-S, Yao M, Shun C-T, Yen M-I, Lee M-C, Chen, Y-C. Isolation of multipotent cells from human term placenta. Stem Cells. 2005; 23(1):3-9.
  7. Wang, Y, Zhao S. Chapter 10, Placental Tissue and Cord Blood Stem Cells. In: Granger N, Granger J, ed. Vascular Biology of the Placenta. San Rafael (CA): Morgan & Claypool Life Sciences; 2010.
  8. daSilva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells. 2008; 26(9):2287-2299.
  9. Richardson SM, Hoyland JA, Mobasheri R, Csaki C, Shakibaei M, Mobasheri A. Mesenchymal Stem Cells in Regenerative Medicine: Opportunities and Challenges for Articular Cartilage and Intervertebral Disc Tissue Engineering. J Cell Physiol. 2010; 222(1):23-32.
  10. National Institute of Health. Regenerative Medicine Fact Sheet. Available at: https://report.nih.gov/NIHfactsheets/Pdfs/RegenerativeMedicine(NIBIB).pdf. Updated October, 2010. Accessed January 20, 2017.
  11. US Department of Health and Human Services. 2020: A New Vision – A Future for Regenerative Medicine. Available at: https://medicine.osu.edu/regenerativemedicine/documents/2020vision.pdf. Published January, 2005. Accessed January 20, 2017.
  12. Dasari VR, Spomar DG, Li L, Gujrati M, Rao JS, Dinh DH. Umbilical Cord Blood Stem Cell Mediated Downregulation of Fas Improves Functional Recovery of Rats after Spinal Cord Injury. Neurochem Res. 2008;33(1):134-149.
  13. Harris DT. Cord Blood Stem Cells: A Review of Potential Neurological Applications. Stem Cell Rev. 2008; 4(4):269-274.
  14. Harris DT. Non-haematological uses of cord blood stem cells. Br J Haematol. 2009;147(2):177-184.
  15. Jazedje T, Secco M, Vieira NM, et al. Stem cells from umbilical cord blood do have myogenic potential, with and without differentiation induction in vitro. J Transl Med. 2009;7:6.
  16. Bliss T, Guzman R, Daadi M, Steinberg GK. Cell Transplantation Therapy for Stroke. Stroke. 2007;38(suppl 2):817-826.
  17. Gluckman E, Rocha V. Donor selection for unrelated cord blood transplants. Curr Opin Immunol. 2006;18:565-570.
  18. Kamani N, Spellman S, Hurley CK, Barker JN, Smith FO, Oudshoorn M, Bray R, Smith A, Williams TM, Logan B, Eapen M, Anasetti C, Setterholm M, Confer DL. State of the Art Review: HLA Matching and Outcome of Unrelated Donor Umbilical Cord Blood Transplants. Biol Blood Marrow Tr. 2008;14(1):1-6.
  19. Schoemans H, Theunissen K, Maertens J, Boogaerts M, Verfaillie C, Wagner J. Adult umbilical cord blood transplantation: a comprehensive review. Bone Marrow Transpl. 2006; 38(2):83-93.
  20. Hogrebe, N.J., Augsornworawat, P., Maxwell, K.G. et al. Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells. Nat Biotechnol 38, 460–470 (2020).
  21. Dawson G, Sun JM, Baker J, et al. A Phase II Randomized Clinical Trial of the Safety and Efficacy of Intravenous Umbilical Cord Blood Infusion for Treatment of Children with Autism Spectrum Disorder [published online ahead of print, 2020 May 14]. J Pediatr. 2020;S0022-3476(20)30334-6. doi:10.1016/j.jpeds.2020.03.011